Sinew Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	31.66	41.39	166.81	246.68	551.17	46.82
Short-Term Investments	1,072	1,118	1,109	1,144	931.49	291.49
Cash & Short-Term Investments	1,103	1,159	1,275	1,391	1,483	338.31
Cash Growth	-9.01%	-9.13%	-8.31%	-6.17%	338.25%	15.58%
Accounts Receivable	-	-	-	-	-	0.15
Other Receivables	23.61	21.43	18.87	16.3	14.3	13.04
Receivables	23.61	21.43	18.87	16.3	14.3	13.19
Prepaid Expenses	0.23	0.05	0.52	0.63	4.22	-
Other Current Assets	0.96	0.73	0.57	-	-	0.4
Total Current Assets	1,128	1,181	1,295	1,408	1,501	351.9
Property, Plant & Equipment	20.39	7.12	18.86	14.35	4.51	7.72
Other Intangible Assets	15.3	22.27	38.51	55.58	67.23	83.33
Other Long-Term Assets	16.63	15.46	10.55	9.15	11.84	10.22
Total Assets	1,180	1,226	1,363	1,487	1,585	453.16
Accrued Expenses	10.12	18.33	22.9	15.36	10.56	7.79
Current Portion of Leases	5.76	2.82	6.46	2.99	1.05	2.29
Current Unearned Revenue	0.52	0.52	0.52	0.52	0.85	-
Other Current Liabilities	4.73	5.52	5.31	4.38	2.65	5.42
Total Current Liabilities	21.13	27.18	35.19	23.25	15.11	15.49
Long-Term Leases	12.27	-	2.82	4.56	-	1.05
Other Long-Term Liabilities	1.7	1.7	1.7	0.85	0.85	0.85
Total Liabilities	35.1	28.88	39.71	28.66	15.96	17.4
Common Stock	713.17	713.15	711.66	697.72	690.09	522.9
Additional Paid-In Capital	825.61	816.47	808.87	900.96	1,067	218.64
Retained Earnings	-386.7	-321.29	-170.92	-140.18	-188.43	-305.78
Comprehensive Income & Other	-6.72	-11.07	-25.95	-	0.43	-
Shareholders' Equity	1,145	1,197	1,324	1,459	1,569	435.76
Total Liabilities & Equity	1,180	1,226	1,363	1,487	1,585	453.16
Total Debt	18.03	2.82	9.28	7.55	1.05	3.34
Net Cash (Debt)	1,085	1,156	1,266	1,384	1,482	334.97
Net Cash Growth	-10.05%	-8.68%	-8.48%	-6.61%	342.31%	16.50%
Net Cash Per Share	15.25	16.21	17.97	19.97	24.90	6.72
Filing Date Shares Outstanding	71.32	71.31	71.17	69.77	69.01	52.29
Total Common Shares Outstanding	71.32	71.31	71.17	69.77	69.01	52.29
Working Capital	1,107	1,154	1,260	1,385	1,486	336.41
Book Value Per Share	16.06	16.79	18.60	20.90	22.73	8.33
Tangible Book Value	1,130	1,175	1,285	1,403	1,502	352.43
Tangible Book Value Per Share	15.85	16.48	18.06	20.11	21.76	6.74
Machinery	12.93	12.93	12.75	7.11	5.83	3.65
Leasehold Improvements	11.28	11.28	11.28	9.31	4.96	4.96

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.